We’re at a crossroads. More people are receiving vaccines as availability improves and hesitancy abates. There’s a slight uptick in cases, but that’s to be expected as restrictions loosen and spring fever overtakes restless young people who haven’t yet been immunized.
But questions remain: Where are we headed? Are things getting better, or are we on the cusp of a dreaded “4th wave”? It’s a schizophrenic time.
Last week, CDC head Rochelle Walensky, proclaimed she had a sense of “impending doom” and implored people to hang in for “just a while longer” and maintain precautions. She said she “can’t face the prospect of another COVID-19 surge”.
But paradoxically, she claimed that the latest data shows that vaccinated people had “zero chance” of spreading the virus. That may be the case, but it’s far from “settled science”.
How do we reconcile these seemingly contradictory statements from a respected medical authority, formerly the head of Infectious Disease at the prestigious Massachusetts General Hospital?
I attribute her downer prognostications to the negativity bias that doctors have. Yes, we are drilled to anticipate the worst. Most Americans who smoke, drink, eat junk food, don’t exercise, and do nothing about their excess pounds blow off their doctors’ advice until they get really sick. Now America is stricken with COVID-19, so all of a sudden, we’re listening attentively to the dire warnings of health authorities we usually ignore. Nerdy doctors are suddenly veritable rock stars, courted by the media, who tend to sensationalize the negative. Politicians may have their own ulterior motives when they tell us to “follow the science” – or not.
So where are we really headed? The answers to these questions will determine the course of the pandemic:
Will people who’ve had COVID-19 enjoy long-lasting immunity? It’s a proposition that’s highly controversial. There are some ominous signs from Brazil that new variants will elude people’s immune defenses acquired from last year’s COVID-19, but other studies suggest that, even if antibodies wane, T-cell memory will confer protection even against new variants. A new test has just been launched to assess T-cell mediated COVID-19 immunity.
Can vaccine recipients still transmit COVID-19? That’s what Dr. Walensky says a new study precludes, but it’s by no means certain. Yes, rarely, some previously vaccinated individuals have tested positive for coronavirus, but they’re usually asymptomatic. Plus, the sensitivity of the PCR nasal swab is such that it might detect the presence of infinitesimal amounts of viral RNA, even when a person has not actually come down with COVID-19. Could they spread it? A new study of college students is underway, testing vaccinees and their immediate contacts, to see if they’re capable of transmitting it. But results won’t be out for at least 5 months!
What about variants? “COVID variants are a “whole new ballgame” warns infectious disease expert Michael Osterholm. He luridly claimed that “We’re in the eye of the hurricane”. Of course, there’s secondary gain for public health officials to “cry wolf”; in addition to drawing attention to themselves, some of their attitudes may be shaped, unfortunately, by their political orientation. But there’s a real possibility some of the new variants (remember, they used to claim the coronavirus RNA was extremely “stable”, unlikely to change as rapidly as the influenza bug, which requires annual updates to the shot) will elude the artificial immunity conferred by the vaccine. But lately some good news is that the Pfizer vaccine remains 91% effective against the pesky new South African variant that threatens to make inroads in the US. Meanwhile, in an abundance of caution, all the major vaccine manufacturers are developing booster shots that can be rolled out later this year if variants evade the protection conferred by first-generation vaccines.
Are children a major source of transmission? An important question, because we don’t want school openings to prompt another surge. And, if kids spread it, this opens the door to widespread vaccination of school kids, even toddlers, which is being seriously proposed. Most studies suggest that adults in school settings are less likely to acquire COVID-19 from pupils than from other adults in the community; moreover, localities that have resumed in-person schooling are usually not faring worse than comparable communities where schools remain shuttered. Again, there’s a lot of political spin invoking contradictory studies to support a chosen narrative, so as schools reopen, we need to follow the data without prejudice.
Will there be long-term side effects of the vaccines? The good news, so far, is that minimal serious immediate reactions are being recorded worldwide. And, even if there’s a tendency for public health authorities and the media to downplay them in the interest of vaccine compliance, more people are taking the shot and reassuring their friends and families that it wasn’t so bad. Hopefully that portends freedom from subtle or overt problems emerging months or even years after vaccination. But we must maintain careful surveillance of vaccinees to assure that long-term problems don’t emerge. And that could be tricky as people succumb naturally over the years, as they inevitably do, to a myriad of health problems. Are they coincidental? Or will vaccine-priming cause certain susceptible individuals (or people who’ve already had COVID-19) to experience immune-related disorders? Even if a tiny minority of recipients are affected, it’s an important consideration to inform future vaccine efforts. Are there categories and subsets of people—albeit small numbers—who shouldn’t get the vaccine? That’s a possibility we can’t preclude.
Will lockdowns, social distancing, and masking make a difference? Especially now that increasing numbers of Americans have been exposed to COVID-19 and/or have taken the vaccine, how necessary is it to maintain rigorous precautions? Unfortunately, lockdown vigilantes and breakout advocates alike can cherry-pick studies to buttress their positions. Politics has even further polarized their entrenched views. A vast uncontrolled experiment is underway pitting compliant localities vs. wide-open precincts; only time will tell which prevails. And beware of selective reporting to validate one or the other ideological narrative—objective science and the ever-elusive virus will have the last word.
In my 40-year history in medicine, I’ve never endorsed a weight-loss product, because most don’t deliver—until now.
The science behind Calocurb and its active ingredient, Amarasate®, is so compelling that I can support it as a plausible alternative for curbing appetite and enhancing satiety to help you shed pounds.
Calocurb works by activating your body’s own appetite-regulating chemical messengers, including GLP-1, which signal specific areas of the brain to effectively manage hunger. It’s safe and effective, with no chemicals, synthetics, or caffeine—and it doesn’t cause jitters.
For a limited time, you can get 10% off your order by using code DH10.
LEARN MORE...
Like Us On Facebook
Leave a question for Dr. Hoffman day or night.The doctor is (always) in!
Our virtual voicemail is open 24/7, so there's no need to wait to submit your questions for Dr. Hoffman. Leave a message, and you may hear your question featured on the Intelligent Medicine radio program!